Version 2.77

Part Descriptions

LP28423-9   West Nile virus
The West Nile Virus (WNV) is an arbovirus that was first identified in the West Nile District of Uganda in 1937. In the fall of 1999, the National Veterinary Services Laboratory (NVLS) isolated WNV in a dead crow in New York City.(http://www.who.int/mediacentre/factsheets/fs354/en/) Over the following ten years, WNV spread throughout the United States, Canada, Mexico and the Carribbean. WNV is usually transmitted through the bite of the Culex mosquito, but can also be spread in blood transfusions, organ transplants, breast milk, intrauterine exposure and laboratory-acquired infections. Birds are the preferred host of WNV, and the American robin is an important amplifier host since it develops enough virus in its serum to infect feeding mosquitoes. Though most infections with WNV are subclinical for humans, between 2005 and 2009 there were 12,975 people infected with WNV, of which 35% had severe cases of neuroinvasive disease and 496 people died. For individuals who are 70 years of age or older, infection with WNV has a 15-29% fatality rate. For infants and immunocompromised patients infected with WNV, the fatality rate is even higher. Diagnosis of WNV is based on clinical symptoms and antibody titers. The IgM antibody-capture enzyme-linked immunosorbent assay (MAC-ELISA) is the key method used to diagnosis WNV in clinical settings. Antibody titers to WNV NS5 are detectable long-term in vivo and can be used to distinguish past infection with WNV from current infection. RNA is usually undetectable in serum after 13.2 days, but on rare occasions, has been found in serum beyond 40 days. Treatment of infection with WNV is mostly supportive. There are no FDA-approved drugs or vaccines available. PMID: 12089283 PMID: 23034323 Source: Regenstrief LOINC

LP6304-2   HAI
The hemagglutination-inhibition assay (HAI) can be used to identify subtypes of hemagglutinin producing viruses, such as Influenza. HAI can also be used to identify the subtype-specificity of antibodies against the virus. Normally, Influenza's hemagglutinin glycoprotein binds to receptors on the surface of red blood cells, causing them to agglutinate. If antibodies specific to the virus are present in the patient sample, they will bind to the virus, which prevents the virus from binding to the red blood cells and therefore prevents agglutination. To determine which subtype of virus is present, a viral isolate is tested against a series of antibodies with known subtype specificities. Whichever antibody inhibits red cell agglutination identifies the viral subtype. Similarly, antibody specificity is identified by testing the patient sample against known virus subtypes. PMID: 24899416 Source: Regenstrief LOINC

Fully-Specified Name

Component
West Nile virus Ab
Property
PrThr
Time
Pt
System
Ser
Scale
Ord
Method
HAI

Additional Names

Short Name
WNV Ab Ser Ql HAI
Display Name
West Nile virus Ab HAI Ql (S)
Consumer Name Alpha Get Info
West Nile virus antibody, Blood

Example Answer List: LL360-9

Source: Regenstrief Institute
Answer Code Score Answer ID
PositiveCopyright http://snomed.info/sct ID:10828004 Positive (qualifier value) LA6576-8
NegativeCopyright http://snomed.info/sct ID:260385009 Negative (qualifier value) LA6577-6

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 2.50
Last Updated
Version 2.56
Change Reason
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
Order vs. Observation
Both

Member of these Groups Get Info

LOINC Group Group Name
LG32768-0 West Nile virus

Language Variants Get Info

Tag Language Translation
es-ES Spanish (Spain) Virus Nilo Occidental Anticuerpos:PrThr:Punto temporal:Suero:Ord:Inhibición de la Hemaglutinación
es-MX Spanish (Mexico) Ab virus del Nilo Occidental:Presencia o umbral:Punto temporal:Suero:Ordinal:Inhibición de la hemaglutinación
fr-CA French (Canada) Virus du Nil occidental , Ac:Présence-Seuil:Temps ponctuel:Sérum:Ordinal:Inhibition de l'hémagglutination
fr-FR French (France) West Nile virus Ac:Présence/Seuil:Ponctuel:Sérum:Qualitatif:Hémagglutination indirecte
fr-BE French (Belgium) Virus du Nil occidental Ac:PrThr:Temps ponctuel:Sérum:Ordinal:Inhibition de l'hémagglutination
Synonyms: Anticorps
it-IT Italian (Italy) Nilo occidentale, virus Ab:PrThr:Pt:Siero:Ord:HAI
Synonyms: anticorpo Inibizione dell''emoagglutinazione Microbiologia Presenza o Soglia Punto nel tempo (episodio) Siero Virus del Nilo occidentale
nl-NL Dutch (Netherlands) West-Nijlvirus As:aanwezigheid:moment:serum:ordinaal:hemagglutinatieremming
Synonyms: antistof; antilichaam
pl-PL Polish (Poland) Wirus gorączki zachodniego Nilu Ab:granica wykrywalności:punkt w czasie:surowica:półilościowy:hamowanie hemaglutynacji
Synonyms: Przeciwciała do wirusa gorączki zachodniego Nilu
tr-TR Turkish (Turkey) Batı Nil virüsü Ab:MevcEşik:Zmlı:Ser:Srl:HAI
Synonyms: Ak Mevcut
zh-CN Chinese (China) 西尼罗河病毒 抗体:存在情况或阈值:时间点:血清:序数型:红细胞凝集抑制试验法
Synonyms: Ab;自身抗体 WNV Ab WNV 抗体 WNV;西尼罗河热;西尼罗河热病毒 传染毒;传染毒素;滤过性病原体;病毒类;过滤性病原体 依次型;分类顺序型;定性的;序数型(或称等级型);性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型 存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况(存在、存在与否、是否存在)或阈值(界值、界限、阀值、临界值) 微生物学;微生物学试验;微生物学试验(培养、DNA、抗原及抗体) 时刻;随机;随意;瞬间 红细胞凝集抑制试验 西尼罗河热病毒 Ab 西尼罗河热病毒抗体 西尼罗河病毒 Ab

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=75404-4